Maximize your research potentialin partnership with RD-Biotech
RD-Biotech is a biotechnology company that offers tailor-made solutions in Molecular Biology, Immunology and Cellular Engineering, as part of Research & Development, pre-clinical or clinical studies. Since its creation in 2002, RD-Biotech provides technical skills and scientific know-how for a personalized, responsive and quality service, and with complete confidentiality.
Our services
RD-Biotech is at your disposal to meet your needs and accelerate your research.
From a feasibility study to the development and production of your biological reagents: DNA, antibodies, recombinant proteins, cells…
Our products
RD-Biotech offers you quality and ready-to-use products, available in catalogue and bulk format…
Ready-to-use cells
RD-Biotech produces and supplies MRC-5, VERO, HEP2 cells, supply of cultured cells or frozen cells, for applications in virology
FastELISA kits
Range of one-step ELISA kits, murine, human, rat Ig quantification, isotyping, protein A, bovine Ig, HCP contaminant detection, and Fc Fusion assay.
Rabies antibodies
Production, monoclonal antibodies anti rabies, D1-25 and 1112-1 clones, quantification by ELISA of rabies virus.
+20
years of experience and expertise
+500
antibodies produced per year
+1500
plasmids produced per year
+98%
response within 24h
"We have the ambition to become a partner of choicein the realization of your projects by saving you timeand allowing you to reduce your operating costs"
— Philippe Dulieu, President of RD-Biotech
Actuality
RD-Biotech: laureate “France Relance, volet Résilience”
On Thursday 30 September 2021, RD-Biotech was pleased to welcome Mr Jean-François Colombet, Prefect of the Doubs, as part of the France Relance plan, Résilience category.
Selected by the French government as part of the France Relance plan, the project to build a GMP-grade production unit will complement our current R&D grade and "High Quality Grade" ("GMP like") plasmid DNA biomanufacturing capacities, in order to answer the growing of market demand in new therapies. Construction will soon begin on the Temis Santé site
Link to the article: RD-Biotech: lauréat sur le volet Résilience - santé
RD-Biotech will participate to the first edition of the Innovative Therapies Days, on October 14 and 15, 2021 in Besancon
First edition of Innovative Therapies Days on 14 and 15 October 2021 in Besancon (25-France) organized by Innov'Health! The meeting of local and international companies specialized in the development and production of innovative therapies involving particular CAR-T cells, stem and pluripotent cells.
RD-Biotech and mAbexperts will be happy to welcome you on the booth number 25 and to discuss with you during the Be To Be meetings.
Custom antibody biomanufacturing & Autumn discounts
Contact us for more information!